85 results
Page 2 of 5
SC TO-T
EX-99
twu3h zi841ob
1 Dec 22
Third party tender offer statement
6:06am
8-K
EX-99.1
g93tw x11ofven
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
SC TO-C
EX-99.1
7duj5
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.2
e17smbdqvzo spqi
7 Nov 22
Information about tender offer
5:26pm
8-K
EX-99.1
8pptmjlv16nf53a hrj
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.2
owf5p
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.1
ibf0smw5nvuwrdar5n3
7 Nov 22
Viatris Reports Strong Third Quarter 2022 Results
7:41am
8-K
EX-99.1
oum1zu7p
8 Aug 22
Viatris Reports Strong Second Quarter 2022 Results
8:02am
8-K
EX-99.1
y65i9on5dw fiw88
9 May 22
Viatris Reports Strong First-Quarter 2022 Results
8:15am
8-K
EX-2.1
g7le5
28 Feb 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
o62m vr1fqoili7
28 Feb 22
Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results and Issues 2022 Financial Guidance
8:24am
8-K
EX-99.1
a8g1kxsp5d10nma
8 Nov 21
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Board of Directors Declares Quarterly Dividend of Eleven Cents ($0.11) per Share
8:27am
DEF 14A
uvtd0p1y
29 Oct 21
Definitive proxy
4:35pm